Sign In
Buy PRTK
$2.23
+0 (+0%)
At Close: Dec 19, 2023
Paratek Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022
04:05pm, Monday, 25'th Jul 2022
BOSTON, July 25, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Wednesday, Aug. 3 at 4:30
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:05pm, Friday, 01'st Jul 2022 GlobeNewswire Inc.
BOSTON, July 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-sa
What to Know About Buying Penny Stocks on June 22nd
11:00am, Wednesday, 22'nd Jun 2022 PennyStocks
Here's what you need to know about trading penny stocks on June 21st
The post What to Know About Buying Penny Stocks on June 22nd appeared first on Penny Stocks to Buy, Picks, News and Information | P
What to Know About Buying Penny Stocks on June 22nd
07:00am, Wednesday, 22'nd Jun 2022
Here's what you need to know about trading penny stocks on June 21st The post What to Know About Buying Penny Stocks on June 22nd appeared first on Penny Stocks to Buy, Picks, News and Information | P
-- Phase 2b Study in MAB Pulmonary Infections Ongoing and Enrolling as Planned
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:15pm, Wednesday, 01'st Jun 2022 GlobeNewswire Inc.
BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-sa
Paratek Pharmaceuticals to Present at the Jefferies 2022 Healthcare Conference
08:05pm, Wednesday, 01'st Jun 2022 GlobeNewswire Inc.
BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-sa
Paratek Pharmaceuticals to Present at the Jefferies 2022 Healthcare Conference
04:05pm, Wednesday, 01'st Jun 2022
BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-savi
Paratek Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
08:05pm, Monday, 16'th May 2022 GlobeNewswire Inc.
BOSTON, May 16, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-sav
Paratek Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
04:05pm, Monday, 16'th May 2022
BOSTON, May 16, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-savin
Paratek Pharmaceuticals (PRTK) Q1 2022 Earnings Call Transcript
04:30pm, Thursday, 05'th May 2022 The Motley Fool
PRTK earnings call for the period ending March 31, 2022.
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2022 Results - Earnings Call Transcript
10:27pm, Wednesday, 04'th May 2022
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Evan Loh - CEO Sarah Higgins - Vice President Finance Controller Adam Woodrow
Paratek Pharmaceuticals Announces First Quarter 2022 Revenue of $24.9 Million
08:05pm, Wednesday, 04'th May 2022 GlobeNewswire Inc.
-- NUZYRA® (omadacycline) Generated Net U.S. Sales of $19.9 Million from the Core Commercial Business, a 51% Increase over First Quarter 2021
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:05pm, Monday, 02'nd May 2022 GlobeNewswire Inc.
BOSTON, May 02, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-sav
Paratek Pharmaceuticals to Report First Quarter 2022 Financial Results on May 4, 2022
08:05pm, Tuesday, 26'th Apr 2022 GlobeNewswire Inc.
BOSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Wednesday, May 4 at 4:3
